FDA Project Team supports the company's proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule, and primary endpoint Final Protocol submission ...

The groundbreaking results of the OVATION 2 Study demonstrated a substantial 35% improvement in overall survival, equating to ...

FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment ...

Susan Wojcicki, the late CEO of YouTube, had a message for the world just weeks before she passed away in August: “Lung ...

A recent trial found that Hyperthermic intraperitoneal chemotherapy (HIPEC) in addition to cytoreductive surgery has ...

The Fussell family has been committed to changing the future of ovarian cancer, ever since hearing Professor Anna deFazio AM ...

Pancreatic cancer, a highly aggressive disease, often diagnosed late, has a low survival rate. Genetic testing provides ...

The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and ...

and lab have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making tumors more receptive ...

and lab have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and ...

Outcomes4Me Inc., the developer of the first direct-to-patient, personalized, and evidence-based cancer navigation platform, and the ...

Looking straight down the barrel of the camera in the first shot as she adopts the classic Demi Moore pregnancy photo pose, ...